Final project plan for Other Technologies CA on MammaPrint® - Added value of using gene-expression signature for adjuvant chemotherapy decisions in early breast cancer assessment (OTCA04)

This is the final project plan of the Other Technologies CA on MammaPrint® - Added value of using gene-expression signature for adjuvant chemotherapy decisions in early breast cancer assessment (OTCA04).

Project Plan